The short half-life of ²¹²Bi and ²¹³Bi limits the application of these radionuclides in α radionuclide therapy. The labeling of biomolecules with ²¹²Pb (mother nuclide of ²¹²Bi) instead of ²¹²Bi or ²¹³Bi has the advantage of obtaining a conjugate with a half-life of 10.6 h, compared with of 60 min for ²¹²Bi or 46 min for ²¹³Bi. Previous attempts to prepare a potential in vivo generator with ²¹²Pb complexed by the DOTA chelator failed, because about 36 % of Bi was reported to escape as a result of the radioactive decay \(^{{212}}{\text{Pb}}{\mathop{\longrightarrow}\limits^{\beta ^{ - }}}{^{212}{\text{Bi}}}\). Herein, we report studies on the stability of the ²¹²Pb complexes with eight selected polydentate ligands, which demonstrate high affinity for 3+ metal cations. From the ligand studied DOTP and BAPTA show a sufficient ²¹²Pb labeling yields but only ²¹²Pb–DOTP complex is stable in isotonic solution of sodium chloride making this way radioactivity level of released ²¹²Bi is below the limit of detection. It should be emphasized that the DOTP complex is stable only in the case when the concentration of free DOTP exceeds 10⁻⁴ M.